IBM Buys HRL Laboratories to Boost Quantum Roadmap, Targeting 100 Million Operations by 2029
Updated
Updated · Yahoo Finance · Aug 31
IBM Buys HRL Laboratories to Boost Quantum Roadmap, Targeting 100 Million Operations by 2029
3 articles · Updated · Yahoo Finance · Aug 31
Summary
IBM said the completed HRL Laboratories acquisition adds quantum sensing, materials science, electronics and manufacturing capabilities to strengthen its push toward scalable quantum systems.
HRL brings silicon-spin qubit expertise that complements IBM’s superconducting approach, along with cryogenics, control electronics, packaging and interconnect technologies across the quantum hardware stack.
IBM said HRL’s silicon-based technologies could also work with Anderon, its quantum wafer foundry, to explore scalable manufacturing methods and support broader quantum infrastructure investment.
The deal fits IBM’s fault-tolerant roadmap, which targets Quantum Starling at 100 million quantum operations by 2029 and Blue Jay as a next-generation system in the mid-2030s.
IBM is expanding in a competitive field where Microsoft is building out Azure Quantum and Alphabet’s Google Quantum AI is advancing superconducting, neutral-atom and error-correction research.
With its stock lagging, is IBM's massive bet on autonomous cryogenic technology enough to dominate the trillion-dollar quantum race?
Will merging 1 Kelvin silicon chips with ultra-cold superconducting systems solve quantum computing's biggest bottleneck or create an engineering nightmare?